Global Adoption Lunit's AI solutions are currently in use at over 3,500 sites worldwide, demonstrating strong international market penetration and a proven track record in diverse healthcare settings, presenting opportunities to expand into new geographic regions and healthcare systems.

Strategic Partnerships Recent collaborations with industry leaders such as Daiichi Sankyo, CellCarta, Agilent Technologies, and Microsoft highlight Lunit's capacity to integrate with top diagnostic and biotech companies, opening avenues for joint sales efforts targeting comprehensive healthcare and precision medicine solutions.

Regulatory Certification Lunit has obtained CE certification for its AI software in Europe, a crucial step in enabling sales to European hospitals and clinics, and indicating readiness to navigate strict regulatory environments for increased market access.

Market Leadership Participation in high-profile events like the World Economic Forum and active engagement in global health initiatives suggest Lunit is positioned as a leading innovator, which can help bolster sales through credibility and visibility in strategic health and technology markets.

Technology Innovation Lunit's AI solutions cover multiple imaging modalities including chest X-ray, mammography, and digital breast tomosynthesis, supporting sales initiatives by offering comprehensive, cutting-edge diagnostic tools suitable for a range of hospital and imaging center needs.